While a gradual loss in muscle strength is a natural part of aging, for many older adults it's more than just feeling a little weaker. Sarcopenia -- a condition affecting nearly half of adults over 80 -- involves a sharp decline in muscle size and strength, increasing the risk of falls and fractures, impacting overall health, life expectancy and quality of life. Now, researchers have identified a game-changing solution. Their recent study suggests that a small molecule drug that targets a specific serotonin receptor could become the first neurotherapeutic treatment for sarcopenia -- offering hope for older adults struggling to stay strong.
http://dlvr.it/TJYnPW
